Sandoz And Aurobindo Cancel US Deal

Billion-Dollar US Oral Solids And Dermatology Deal Called Off

 
• By Dave Wallace

Sandoz and Aurobindo have mutually agreed to terminate their billion-dollar agreement that would have seen the Indian company acquire Sandoz’ dermatology and oral solids businesses in the US, citing a delay in FTC approval for the deal.

Broken handshake
Sandoz and Aurobindo have called off their billion-dollar US deal • Source: Shutterstock

Sandoz and Aurobindo have cancelled their billion-dollar deal through which the Indian company was planning to acquire Sandoz’ generic oral solids and dermatology businesses in the US.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Generics Bulletin for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Deals

More from Business